Benchmark analysts have adjusted the price target for MKS Instruments (NASDAQ:MKSI) to $135 from the previous $142 while maintaining a Buy rating on the stock. The current analyst consensus remains ...
Deutsche Bank analyst Melissa Weathers lowered the firm’s price target on MKS Instruments (MKSI) to $110 from $120 and keeps a Hold rating on ...
Needham analysts adjusted their outlook on MKS Instruments (NASDAQ:MKSI), reducing the price target from $156.00 to $145.00, yet reaffirming a Buy rating on the stock. The revision comes amid concerns ...
Thank you for standing by and welcome to the MKS Instruments’ Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, today’s program is being recorded. And now, I’d like ...
Discover key insights from MKS Instruments' Q4 2024 earnings call, including revenue growth, strategic investments, and an optimistic 2025 outlook.
Shares of Marks & Spencer Group PLC MKS rose 1.69% to £3.56 Thursday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index UKX falling 0.49% to ...
Quarterly revenue of $935 million, above the midpoint of guidance Quarterly GAAP net income of $90 million and net income per diluted share of ...
For the current quarter ending in March, MKS Instruments expects its per-share earnings to range from $1.13 to $1.67. The company said it expects revenue in the range of $870 million to $950 million ...
Gold prices have marched into uncharted territory as bulls latch on to economic uncertainty created by U.S. import tariff ...
Prognostic significance of pigmentation and stem cell markers in Indian population of uveal melanoma
Background Increased pigmentation has been associated with cancer stem-cell-like behaviour and chemoresistance in uveal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results